Efficient SMN Rescue following Subcutaneous Tricyclo-DNA Antisense Oligonucleotide Treatment
Spinal muscular atrophy (SMA) is a recessive disease caused by mutations in the SMN1 gene, which encodes the protein survival motor neuron (SMN), whose absence dramatically affects the survival of motor neurons. In humans, the severity of the disease is lessened by the presence of a gene copy, SMN2....
Saved in:
Main Authors: | Valérie Robin (Author), Graziella Griffith (Author), John-Paul L. Carter (Author), Christian J. Leumann (Author), Luis Garcia (Author), Aurélie Goyenvalle (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model
by: Karima Relizani, et al.
Published: (2017) -
Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mdx52 mice
by: Amel Saoudi, et al.
Published: (2023) -
Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 Transcript
by: Loren L. Flynn, et al.
Published: (2018) -
Link between MHC Fiber Type and Restoration of Dystrophin Expression and Key Components of the DAPC by Tricyclo-DNA-Mediated Exon Skipping
by: Saleh Omairi, et al.
Published: (2017) -
Deep learning facilitates efficient optimization of antisense oligonucleotide drugs
by: Shenggeng Lin, et al.
Published: (2024)